The extracellular matrix PCM) is essential in regulating many cell functions in non-lymphoid cells, and the ECM may also play a role in the function of the immune system. Tenascin is a hexameric glycoprotein of the ECM. In mouse, two major polypeptides of MW 210 KD and 260 KD are formed by differential splicing. Northern blot screening of various mouse tissues showed that the short 6 KB tenascin message was strongly expressed in the adult thymus, whereas very little or no tenascin mRNA could be detected in spleen. In addition, immunoblotting and histological analysis with monoclonal anti-tenascin antibodies revealed the presence of tenas-
In troduaion
The extracellular matrix (ECM) has been shown to be critical for regulating diverse physiological events, including embryogenesis. In the immune system the ECM is involved in lymphocyte differentiation, migration, and activation. Since lymphocytes can interact with and respond to many different types of microenvironments, they have a variety of ECM receptors. Therefore, ECM components may be vital to immune function (8, 12, 19, 28, 30) .
Large numbers of lymphocytes collect in lymphoid tissue, which is a modified form of connective tissue. Except for the thymus gland, the stroma of lymphoid tissue consists of reticular fibers and closely associated reticular cells. The "reticular cells" of the primary lymphoid organ, thymus, differ from the reticular cells in the secondary lymphoid tissues, spleen and lymph nodes. They develop from endoderm rather than mesenchyme, they are not closely associated with reticular fibers, and they are not considered the source of reticular fibers. They retain an epithelioid character by forming a cytoreticulum within the thymus and are called epithelial reticular cells (7,23,31).
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Correspondence to: Goran Ocklind, Dept. of Zoophysiology, Uppsala U., Norbyvagen 18A, 752 32 Uppsala, Sweden. cin in lymph nodes and spleen. In thymus, only a shortsplice variant of tenascin was detected by immunoblotting, which supported the Northem blot results. Immunohistology showed that the epithelial reticular stroma in both embryonic and adult mouse thymus expressed tenascin, as did the postnatal mesenchymal reticular stroma in lymph nodes and spleen. The distribution of tenascin in the thymus was more restricted than that of fibroneain and laminin. (1 Hisrochem Cytochem 41:1163 -1169 , 1993 KEY WORDS: Tenascin; Thymus; Spleen; Lymph node.
Among the ECM glycoproteins, the immune function of fibronectin, collagen, and laminin have been studied (8,19,28), but the lesser-known ECM molecule in this context is tenascin. Tenascin is found in several normal tissues and appears in the stroma of many tumors. In vertebrate embryos, tenascin expression is present in the mesenchymal components of various organs (10,ll). It has been found in red pulp sinusoids (4), trabeculae, and cord of spleen, and in capsule and trabeculae of lymph node (22).
In a Northern blot screening of various mouse tissues, we noted that the 6 KB tenascin mFWA was particularly strongly expressed in the adult thymus, and a similar finding was recently reported by Saga et al. (26) . These findings and the recent suggestion that tenascin may affect the activation of lymphocytes (25) prompted us to study the distribution of tenascin in thymus and in other lymphoid organs. We found that the epithelial reticular stroma in embryonic and adult mouse thymus was expressing tenascin. Tenascin was also seen in trabeculae, capsule, and vessels in postnatal lymph nodes and spleen.
Materials and Methods
Northern Blotting. Total RNAs from brain hemisphere, cerebellum, skin, heart, kidney, liver, lung, skeletal muscle, testes, spleen, and thymus, derived from four FVB male mice, were isolated according to the method of Auffray and Rougeon (3) . Briefly, tissue samples were homogenized for OCKLIND. TALTS, FASSLER, MATTSSON, EKBLOM was collected by 15-min centrifugation at 1500 x g. RNA pellets were dissolved in protease K digestion buffer (10 mM Tris, pH 7.5, 0.5% SDS. 50 pglml proteinase K) and subsequently incubated at 37°C for 30 min. After two phenol and one chloroform extractions. total RNA was precipitated. washed in 70% ethanol. and dissolved in 200 pI of RNAse-free water.
Ten pg of total RNA was electrophoretically separated, blotted onto Zetaprobe membrane (Bio-Rad; Richmond, CA) (27). uV-crosslinked. and probed in Church buffer (6) at 65°C with an oligolabeled tenascin cDNA fragment (pr-5'6) corresponding to the 5'region of the cloned cDNA. After hybridization the blot was washed twice for 30 min at 65°C in a solution containing 0.1 x SSC and 1% SDS. Finally. the blot was exposed for 3 days at '-70'C on a Kodak X-OMAT film, after which the film was developed.
Western Blotting. The tenascin extraction buffer was composed of 200 mM 3-(cyclohexylamino)-I-propanesulfonic acid (CAPS; adjusted with NaOH to pH 11.0). 150 mM NaCI. 1 mM EDTA, 2 mM phenylmerhylsulfonyl fluoride (PMSF). 1% aprotinin (Trasylol; Bayer, Leverkusen. Germany), and 2 mM N-erhylmaleimide (NEM). Two-times-concentrated sample buffer was composed of 40% glycerol. 6% SDS, 200 mM dithiotreitol (D'IT) in 100 mM Tris-HCI. pH 6.8, and a few crystals of bromophenol blue.
Tissues were homogenized by ultrasonic treatment in about five volumes of extraction buffer and were then shaken for 15 min at 4'C. after which the extracts were neutralized with 2 M NaHzP04.
Protein concentrations were determined with a Bio-Rad prorein assay kit. Equal volumes of tissue extract and double-concentrated sample buffer were mixed, heated for 3 min at 95"C, centrifuged for 3 min at 14,000 b b 28s 18s i Figure 1 . Analysis of the size of mouse tenascin mRNAs by Northern blotting. Signals of close to 6 KB were detected in RNA from thymus, skin, and cerebellum. One signal representing about 8 KB was detected in lung. rpm in a Heraeus Biofuge 11, and 30 pI conraining 150 pg protein was added to the sample wells on the gel. For electrophoresis we used a pre-cast 4-15% Tris-HCI gradient gel (Mini-PROTEAN; Bio-Rad) at 200 V, with Trisglycine-SDS running buffer. As protein MW markers, pre-stained standards within the range M W 14.300-200.000 were used (Rainbow; Amersham Sweden AB. Solna. Sweden).
Electrophoretic transfer to nitrocellulose membrane (0.45 pm) (Schleicher & Schuell; Dassel, Germany) was done in a Mini Trans-Blot apparatus (Bio-Rad). To prevent nonspecific binding of antibodies. the nitrocellulose membrane was incubated for 1 hr at RT in 3% crystalline BSA (Cohn fraction V) (Sigma; St Louis, MO) in TBS-Tween. The membrane was incubated for 4 hr at RT in hybridoma supernatant containing the anti-mouse renascin MAb MTn 12 and washed five times for 5 min in TBS-Tween. The same procedure was repeated with the second antibody, biotinylared sheep antirat Ig, diluted 1:200 (Amersham; Poole. UK)and with the horseradish peroxidase-avidin-biotin complex (ABC Elite) (Vector: Burlingame, CA). For color development, 4-chloro-1-naphthol (Sigma) in 50 mM Tris-HCI. pH 7.6. was used.
ABC Immunohistochemistry. Tissues obtained from DBA mice were embedded in OCT compound (Tissue-Tek) (Miles, Elkhart. IN) and frozen rapidly on isopentaneldry ice. Cryosections 4 pm thick were fixed in acetone at RT for 4 min. rehydrated in PBS, incubated in PBS supplemented with 5 % normal goat serum to block nonspecific binding of immunoglobulin to tissue, and incubated for 1 hr at RT with hybridoma culture supernatant conraining one of the following Ab: rat anti-mouse tenascin MAb with 0.0025% H202. The sections were then washed in distilled water, counterstained with hematoxylin, and mounted in Kaiser's glycerol-gelatin containing thimerosal as preservative instead of phenol.
Results
In 10 pg total RNA we could detect the 6 KB tenascin mRNA in cerebellum, skin, and strong expression in thymus by Northern blotting of adult mouse tissues. The 8 KB form was detected in lung, whereas no tenascin mRNA was detected in brain hemisphere, heart, kidney, liver, skeletal muscle, spleen, or testes ( Figure 1) . Because of the strong expression in thymus, lymphoid organs were studied in more detail by immunocytochemistry and Western blotting. Western blots of tissues from 14-day postnatal mice showed a strong band at about 200 KD for thymus, indicating the presence of the low molecular weight form of tenascin, whereas the longer splice variant of tenascin could not be detected. The spleen was represented by two weak bands at about 200 KD and 230 KD, suggesting that both forms of tenascin were present. In the lymph node lane, only one faint band at about 200 KD was seen (Figure 2) . The band at about 130 KD is probably not a degradation product of tenascin, since it was also present in the control done with normal rat IgG (not shown).
Cryosections of embryonic and postnatal thymus, spleen, and lymph node stained by the peroxidase-ABC method were all positive for the anti-tenascin MAb MTn 12. Control staining with pre-I immune anti-rat IgG revealed a positive reaction of some macrophages in spleen, most likely due to Fc-receptor binding (not shown).
Sections of 13-day embryo and adult thymus reacted with either anti-fibronectin MAb or with anti-laminin A-.B-chain antibodies revealed a less restricted distribution of these molecules in the ECM as compared with tenascin (Figure 3 ). Laminin and fibronectin were expressed throughout the 13-day thymus stroma and also in the capsule, whereas tenascin was restricted to the epithelial medullary part of the primordium (Figures 3A-3C) .
In thymus from juvenile (4 day) and adult (8 week) mice, tenascin was distinctly localized in capsule, septa, trabeculae, medullary epithelial reticulum, and around vessels (Figures 3D, 3G, and 3H) .
There was strong localization of tenascin to the basement membranes of the epithelial cells that completely enclosed the blood vessels and to the epithelial basement membrane of the sheathlike intrathymic lymph vessels that accompany the medullary blood vessels ( Figures 4A and 4B ).
Spleen and lymph node from the same juvenile and adult animals showed a similar localization of tenascin to basement membranes. In lymph node capsule, trabeculae, and blood vessels were intensely labeled, whereas reticular fibers exhibited less reaction product ( Figure >A) . Io spleen tenascin was mainly localized to capsule, trabeculae, marginal zone sinuses, sinusoids of the red pulp. and blood vessels, whereas reticular fibers stained less intensely ( Figures 5B and 5C ). Especially conspicuous was the strong staining of the marginal zone sinuses ( Figure 5B ). Adult spleen was also stained with anti-fibronectin and anti-laminin. In contrast to the localization of tenascin, laminin and fibronectin had a less restricted distribution, appearing more than tenascin in the reticular stroma (Figures 5 C-5 E).
Discussion
We show here that tenascin is prominently expressed focally in the stroma of the adult thymus. Tenascin is an extracellular matrix glycoprotein composed of six subunits. The individual subunits may vary in size because of altemative splicing. In mouse, the two major isoforms have a size of about 210 and 260 KD. The biological role of native tenascin is still unclear, but recent evidence suggests that it modulates cell adhesion and that it has anti-adhesive properties (20,29). We found that the adult thymus expresses large amounts of tenascin. Interestingly, only the shorter splice variant was detected in the thymus by Northern and Western blotting. In the spleen two bands were detected by immunoblotting. A major finding of this study is that the adult thymus actively produces extracellular matrix, as indicated by the Northern blots.
The continued synthesis of tenascin in adult thymus suggests that ECM production is important for some physiological events in the thymus. The short form of tenascin or other ECM components coregulated with it in the thymus may be involved in lymphocyte trafficking. Investigations of tenascin have predominantly concerned its appearance in mesenchyme during development, and it has been proposed that actively growing, migrating, and differentiating epithelial sheets can produce factors that stimulate tenascin expression in the nearby mesenchyme (1,2,9,14) . Although tenascin is produced by mesenchymal cells, the glycoprotein has also O C " D , TALTS, aSSLER, MATISSON, EKBLOM been found in a few epithelial compartments. During development in chicken it has been localized in corneal epithelium (15), choroid plexus epithelium, and lung epithelium (24). Our data suggest that the epithelial stroma in thymus produces tenascin and that in the postnatal organ only the shorter form is expressed.
The two major mouse tenascin polypeptides are differentially expressed during development. The 8 KB mRNA dominates in prenatal kidney development, but postnatally the 6 KB message is most prominent. A different expression pattern is seen in the mesenchyme of the developing gut, where the 210 KD polypeptide dominates during embryogenesis and the 260 KD polypeptide appears later (2). A shift in molecular forms similar to that in the gut does not seem to occur during development of the thymus (26). The epithelial meshwork of the thymus develops from an outpushing of the gut endoderm of the third pharyngeal pouch. The third and fourth pouches of the anterior endoderm with attached ectoderm penetrate the surrounding mesoderm to initiate formation of the thymus and parathyroid. The thymus rudiment then detaches and migrates down into the chest cavity, where it actively collects T-cell precursors from the blood (7,23,31). Even though thymus and gut have the same origin, the epithelial cells of the gut do not express tenascin but rather induce production of the glycoprotein in the mesenchyme (2). Our study shows that tenascin is expressed by the epithelial cells early during embryonic development of the thymus. How the production of tenascin in the embryonal epithelial cells is induced remains to be clarified. Hypothetically, during thymus development the rapidly proliferating ectoderm could induce expression of tenascin in the endodermal compartment, since it has been reported that rapidly proliferating epithelial cells can induce adjacent cells to produce tenascin (2, 14) .
Functionally, little is known about tenascin in lymphoid tissue. It has been shown that tenascin has in vitro immunomodulatory effects (25). It is an open question whether effects of tenascin on immune cells should be mediated directly by lymphocyte surface integrins or not, since mouse tenascin does not contain an RGD motif (32). An RGD domain is a typical feature of many ECM proteins such as fibronectin and laminin, whereas the integrin VLA-4 does not recognize an RGD motif (13). The ECM protein laminin has been demonstrated in blood vessels and reticular fibers of T-celldependent areas of human lymph nodes (17). Laminin seems to be important for lymphocyte traffic, since anti-laminin treatment of rats partially prevents lymphocytes from entering lymph nodes (18). Our staining results with the anti-tenascin MAb MTn 12 suggest that tenascin is strongly associated with vessels. In thymus, tenascin was localized to the basement membrane of the epithelial cells that envelop the blood vessels and that envelop multiplying lymphocytes. The epithelium of the thymus is crucial for intrathymic T-cell development in the positive and negative selection of the T-cell repertoire (31). In spleen, tenascin was abundant in marginal zone sinuses and red pulp vessels. The marginal zone sinuses harbor an abundance of blood antigens and many phagocytic macrophages. This area plays a significant role in filtering the blood and establishing the immune response (5,2133). Tenascin has been suggested to contain both a cell-binding site and an anti-adhesive site (29). Therefore, one role of tenascin in the body fluid barriers of thymus and secondary lymphoid organs might be, in cooperation with other ECM molecules, to regulate the passage of lym-phocytes to and from the circulation. Since nothing is known about tenascin receptors on lymphoid cells, it is not yet possible to propose a mechanism for an eventual interplay between immune cells and tenascin.
